HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Personal CFO Solutions LLC

Personal CFO Solutions LLC lessened its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 32.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,168 shares of the company's stock after selling 1,051 shares during the quarter. Personal CFO Solutions LLC's holdings in HCA Healthcare were worth $749,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Sanders Capital LLC increased its stake in HCA Healthcare by 1.0% during the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock worth $3,498,417,000 after acquiring an additional 116,826 shares during the last quarter. First Eagle Investment Management LLC grew its stake in shares of HCA Healthcare by 0.5% in the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company's stock valued at $1,351,830,000 after buying an additional 23,177 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of HCA Healthcare by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock valued at $1,159,882,000 after buying an additional 50,321 shares in the last quarter. Capital World Investors grew its stake in shares of HCA Healthcare by 0.7% in the fourth quarter. Capital World Investors now owns 2,928,452 shares of the company's stock valued at $878,975,000 after buying an additional 19,121 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at $840,286,000. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

HCA has been the subject of a number of research reports. Stephens raised HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday. Morgan Stanley set a $410.00 target price on HCA Healthcare and gave the stock an "equal weight" rating in a research note on Monday, June 9th. Royal Bank Of Canada reissued an "outperform" rating and set a $404.00 target price (up from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Finally, Barclays set a $416.00 target price on HCA Healthcare and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Seven equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $395.71.

HCA Healthcare Stock Down 0.3%

HCA Healthcare stock opened at $377.71 on Wednesday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The company has a market capitalization of $90.87 billion, a P/E ratio of 16.79, a PEG ratio of 1.31 and a beta of 1.47. The stock has a 50-day simple moving average of $373.21 and a 200-day simple moving average of $340.45.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the business earned $5.36 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend was Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.